Head-to-head comparisons of medication uses, side effects, warnings, and more.
Soliqua 100/33
Insulin degludec (Tresiba)
Soliqua 100/33
Insulin degludec (Tresiba)
Summary of Soliqua 100/33 vs. Tresiba
Summary for Insulin / GLP-1 agonist
Prescription only
Soliqua 100/33 is a combination medication for diabetes that contains insulin glargine (a long-acting insulin) and lixisenatide (a glucagon-like peptide-1 (GLP-1) receptor agonist). It helps manage blood sugar levels along with diet and exercise in adults with Type 2 diabetes. The medication comes as a prefilled pen and is injected under the skin once a day within 1 hour before you eat your first meal of the day. Soliqua 100/33 commonly causes stomach-related side effects like nausea and diarrhea.